scholarly journals B-PO05-215 SINUS NODE DYSFUNCTION DURING PERICARDIAL ABLATION OF A REFRACTORY MITRAL ISTHMUS-DEPENDENT ATRIAL FLUTTER

Heart Rhythm ◽  
2021 ◽  
Vol 18 (8) ◽  
pp. S460
Author(s):  
Poojita Shivamurthy ◽  
Vivek Reddy ◽  
Jacob Koruth
Keyword(s):  
Atrial Flutter ◽  
Sinus Node ◽  
Sinus Node Dysfunction ◽  
Mitral Isthmus

Atrial tachyarrhythmias in bradycardia–tachycardia syndrome: characterization and evolution

ESC CardioMed ◽  
2018 ◽  
pp. 1954-1957
Author(s):  
Luigi Padeletti ◽  
Roberto De Ponti
Keyword(s):  
Atrial Fibrillation ◽  
Atrial Flutter ◽  
Sinus Node ◽  
Ventricular Myocardium ◽  
Sinus Node Dysfunction ◽  
Ventricular Pacing ◽  
Atrial Tachyarrhythmia ◽  
Atrial Tachyarrhythmias ◽  
Node Disease ◽  
Sinus Node Disease

The association of sinus node disease and atrial tachyarrhythmias characterizes the bradycardia–tachycardia syndrome, which may result in an increased risk of heart failure, stroke, and death. Ageing and several cardiac and extracardiac diseases, which have the potential to affect both the atrial and the ventricular myocardium, can manifest their influence predominantly on the atria, leading to an atrial cardiomyopathy. In these cases, the same pathological process which leads to sinus node dysfunction can create a favourable substrate also for atrial tachyarrhythmias, which, if not present at the time of the initial diagnosis of the sinus node disease, can occur with an increasing prevalence during follow-up. In younger patients with no evident structural heart disease, a bradycardia–tachycardia syndrome may be the first clinical and unexpected manifestation of a still undiagnosed inherited genetic disease and therefore a specific diagnostic workup is necessary. In bradycardia–tachycardia syndrome, the most frequently encountered atrial tachyarrhythmia is atrial fibrillation, while typical atrial flutter is rarer. In peculiar subgroups of patients, other atrial tachyarrhythmias, such as atypical atrial flutter, macroreentrant or focal atrial tachycardia, may be present. In bradycardia–tachycardia syndrome, the evolution of atrial tachyarrhythmias clearly shows a worsening with an prevalence of associated atrial tachyarrhythmia over time. Pharmacological therapy for arrhythmias is of limited use, due to the concomitant sinus node dysfunction. The modality of pacing used to manage the sinus node disease has to be carefully chosen to minimize the evolution of atrial tachyarrhythmias. In fact, while ventricular pacing increases the incidence of atrial fibrillation and stroke, dual-chamber pacing with a specific algorithm for ventricular pacing minimization and prevention and treatment of atrial tachyarrhythmias reduces a composite endpoint of evolution to permanent atrial fibrillation, hospitalization, and death.

scholarly journals Prediction of sinus node dysfunction in patients with persistent atrial flutter using the flutter cycle length

EP Europace ◽  
2011 ◽  
Vol 14 (3) ◽  
pp. 380-387 ◽  
Author(s):  
A. Sairaku ◽  
Y. Nakano ◽  
N. Oda ◽  
Y. Makita ◽  
K. Kajihara ◽  
...  
Keyword(s):  
Atrial Flutter ◽  
Cycle Length ◽  
Sinus Node ◽  
Sinus Node Dysfunction

scholarly journals Emery-Dreifuss muscular dystrophy presenting as a heart rhythm disorders in children

2021 ◽  
Vol 42 (Supplement_1) ◽  
Author(s):  
T S Kovalchuk ◽  
E V Yakovleva ◽  
S G Fetisova ◽  
T L Vershinina ◽  
T M Pervunina ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Skeletal Muscle ◽  
Muscular Dystrophy ◽  
Atrial Flutter ◽  
Sinus Node ◽  
Heart Rhythm ◽  
Sinus Node Dysfunction ◽  
Supraventricular Arrhythmias ◽  
Heart Rhythm Disorders ◽  
The Mean

Abstract Introduction Emery-Dreifuss muscular dystrophy (EDMD) is an inherited muscle dystrophy often accompanied by cardiac abnormalities in the form of supraventricular arrhythmias, conduction defects, sinus node dysfunction. Cardiac phenotype typically arises years after skeletal muscle presentations, though, can be severe and life-threatening. The disease usually manifests during the third decade of life with elbow joint contractions and progressive muscle weakness and atrophy. Objective To present our clinical experience of diagnosis and treatment of arrhythmias in children with Emery-Dreifuss muscular dystrophy Materials and methods We enrolled 5 patients with different forms of EDMD (X-linked and autosomal dominant) linked to the mutations in EMD and LMNA genes, presented with early onset of cardiac abnormalities and no leading skeletal muscle phenotype. The predominant forms of cardiac pathology were atrial flutter, atrial fibrillation and conduction disturbances that progress over time. Clinical examination included physical examination, 12-lead electrocardiography, Holter ECG monitoring (HM), transthoracic echocardiography, neurological examination and biochemical and hormone tests. Also we performed CMR, electrophysiological study (EPS), treadmill test of some patients. One patient underwent an endomyocardial biopsy to exclude inflammatory heart disease. Target sequencing was performed using a panel of 108 or 172 genes Results We observed five patients with EDMD and cardiac debut during first-second decades of life: 3 with 1st subtype (variants in EMD gene) and 2 with 2nd subtype (variants in LMNA gene). All patients were males. The mean age of cardiac manifestation was 13,2±3,11 (from 9 to 16 y.o.). The mean follow-up period was 7,4±2,6 years. All patients presented with sinus node dysfunction and four out of five with AV conduction abnormalities. The leading arrhythmic phenotypes included various types of supraventricular arrhythmias: multifocal atrial tachycardia (AT) (n=4), premature atrial captures (PACs) (n=4), atrial flutter, (AF) (n=3), atrial fibrillation (AFib) (n=3) and AV nodal recurrent tachycardia (AVRNT). Heart rhythm disorders were the first manifestation in all three patients with 1st EDMD subtype. Radiofrequency ablation was performed in 2 patients, one of them received permanent pacemaker implantation. Conclusions In conclusion, while being the rare cases, heart rhythm disorders can represent the first and for a long time, the only clinical symptom of EDMD even in the pediatric group of patients. Therefore, thorough laboratory and neurological screening along with genetic studies, are of importance in each pediatric patient presenting with complex heart rhythm disorders of primary supraventricular origin to exclude EDMD or other neuromuscular disorders. FUNDunding Acknowledgement Type of funding sources: None.

scholarly journals Sinus node dysfunction after atrial flutter ablation - a preventable complication

2013 ◽  
Vol 34 (suppl 1) ◽  
pp. 1708-1708
Author(s):  
J. J. Hai ◽  
S. K. Mulpuru ◽  
E. E. Williamson ◽  
T. A. Foley ◽  
Y. Cha ◽  
...  
Keyword(s):  
Atrial Flutter ◽  
Sinus Node ◽  
Sinus Node Dysfunction ◽  
Preventable Complication ◽  
Atrial Flutter Ablation

scholarly journals Rescue Percutaneous Coronary Intervention for Sinus Node Dysfunction Following Left Atrial Flutter Ablation

2021 ◽  
Author(s):  
Yuichiro Miyazaki ◽  
Nobuhiko Ueda ◽  
Fumiyuki Otsuka ◽  
Koji Miyamoto ◽  
Teruo Noguchi ◽  
...  
Keyword(s):  
Percutaneous Coronary Intervention ◽  
Atrial Flutter ◽  
Left Atrial ◽  
Sinus Node ◽  
Coronary Intervention ◽  
Sinus Node Dysfunction ◽  
Percutaneous Coronary ◽  
Atrial Flutter Ablation

P.2.2 The use of adenosine in diagnosis of sinus node dysfunction

EP Europace ◽  
2003 ◽  
Vol 4 ◽  
pp. A40
Author(s):  
A PIETRUCHA
Keyword(s):  
Sinus Node ◽  
Sinus Node Dysfunction

scholarly journals Ventricular pacing or dual-chamber pacing for sinus-node dysfunction

2002 ◽  
Vol 11 (6) ◽  
pp. 75-76 ◽  
Author(s):  
G.A. Lamas ◽  
K.L. Lee ◽  
M.O. Sweeney
Keyword(s):  
Sinus Node ◽  
Sinus Node Dysfunction ◽  
Ventricular Pacing ◽  
Dual Chamber ◽  
Dual Chamber Pacing
Sign in / Sign up

Export Citation Format

Share Document